Form 4: Singular Genomics Systems CEO Andrew Spaventa Reports Stock Transactions
SEC Form 4
CEO Andrew Spaventa reports stock transactions including RSU settlements, tax withholdings, and gifts to a living trust, following a reverse stock split.
Summary
- On August 12, 2024, Andrew Spaventa, CEO of Singular Genomics Systems, Inc., reported several transactions involving the company's common stock.
- These transactions include the settlement of vested Restricted Stock Units (RSUs) resulting in the issuance of 1,906 shares, adjusted for a 1-for-30 reverse stock split that occurred on June 26, 2024.
- The CEO also had 681 shares withheld by the issuer to cover tax obligations related to the RSU settlement at a price of $7.12 per share.
- Following the RSU settlement and tax withholding, Spaventa gifted 1,225 shares to The Andrew K. Spaventa Living Trust dated April 9, 2014.
- Spaventa also indirectly owns shares through Axon Holdings, LLC, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing detailing stock transactions. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and provide transparency to investors regarding the buying and selling activities of company executives and directors.
Related Party Transactions
- The gift of shares to The Andrew K. Spaventa Living Trust dated April 9, 2014, is a related party transaction.
- The shares held by Axon Holdings, LLC, where Andrew Spaventa is a managing member, constitute a related party holding.
Stakeholder Impact
- Shareholders are informed about the CEO's stock transactions, providing transparency.
- The transactions have a minor impact on the overall share structure, especially considering the reverse stock split.
Key Dates
| Date | Description |
|---|---|
| April 9, 2014 | Date of The Andrew K. Spaventa Living Trust. |
| February 12, 2024 | Date from which the RSUs vest in 16 equal quarterly installments over four years. |
| June 26, 2024 | Date of the 1-for-30 reverse stock split. |
| August 12, 2024 | Date of the reported transactions, including RSU settlement, tax withholding, and gift. |
| August 14, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.